RPGLIFE vs WOCKPHARMA: Stock Comparison

RPG LIFE SCIENCES vs WOCKHARDTUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. RPG LIFE SCIENCES shows a lower P/E, a higher ROE and a higher dividend yield, while WOCKHARDT shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

RPGLIFE leads 9; WOCKPHARMA leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

RPGLIFEWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹4,515 Cr
₹33,908 Cr
P/E RatioRPGLIFE has the lower reading
51.42x
75.68x
P/B RatioWOCKPHARMA has the lower reading
7.03x
6.27x
EPSRPGLIFE has the higher reading
₹18.6
₹6.58
Book ValueContext only
₹366.03
₹325
Dividend YieldRPGLIFE has the higher reading
0.91%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹33,908 Cr vs ₹4,515 Cr
P/E Ratio
RPGLIFE has a lower P/E
51.42x vs 75.68x
P/B Ratio
WOCKPHARMA has a lower P/B
6.27x vs 7.03x
EPS
RPGLIFE has higher earnings per share
₹18.6 vs ₹6.58
Dividend Yield
RPGLIFE has a higher dividend yield
0.91% vs 0%
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs 23.6%
EPS Growth (TTM YoY)
WOCKPHARMA has faster EPS growth
0% vs -74.5%
Qtr Sales Growth
RPGLIFE has stronger quarterly sales growth
0% vs -39.61%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricRPGLIFEWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricRPGLIFEWOCKPHARMA
Live Price₹2,721.6₹2,088.7
Day Change2.61%7.08%
Volume20,46335.58 L
52-Week High₹3,082₹2,422.3
52-Week Low₹1,733₹1,086.7
Distance from 52W High-11.69%-13.77%

Valuation

MetricRPGLIFEWOCKPHARMA
Market Cap₹4,515 Cr₹33,908 Cr
P/E Ratio51.42x75.68x
P/B Ratio7.03x6.27x
EPS₹18.6₹6.58
Book Value₹366.03₹325
Dividend Yield0.91%0%

Growth

MetricRPGLIFEWOCKPHARMA
Revenue Growth (TTM YoY)23.6%26%
EPS Growth (TTM YoY)-74.5%0%
Qtr Sales Growth0%-39.61%
Qtr Profit Growth0.62%0%

Profitability & Leverage

MetricRPGLIFEWOCKPHARMA
ROE19.02%10.28%
ROCE24.39%10.37%
Net Margin29.25%3.3%
Operating Margin21.92%28.35%
Debt to Equity0.03x0.57x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricRPGLIFEWOCKPHARMA
Promoter Holding72.95%49.08%
FII Holding0.95% 0.08 pp7.22% 0.13 pp
DII Holding8.67% 1.22 pp9.24% 1.72 pp
Public Holding17.42% 1.31 pp34.44% 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: RPG LIFE SCIENCES and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.